A Single Dose to End Sleeping Sickness
A single dose of three tablets. No hospital stay. Free to patients. After two decades of collaborative research across Africa and Europe, DNDi and Sanofi have developed a new oral treatment for sleeping sickness that has cleared a major regulatory hurdle. The WHO’s 2030 elimination target now looks achievable.